Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze EW stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate EW investment potential.

What is EW stock price today?

Get real-time EW stock price, historical data, and price charts on Financhill. Track EW performance with our advanced analysis tools.

Is EW a good investment?

Evaluate EW investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

To buy EW stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of EW?

View detailed market capitalization data and company valuation metrics for EW on our comprehensive analysis page.

What is the P/E ratio of EW?

Use our fundamental analysis tools to view EW P/E ratio and compare valuation metrics with industry peers.

What are EW earnings?

View EW earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Edwards Lifesciences Corp. 10K Form

Buy

EW
Edwards Lifesciences Corp.

Last Price:

$79.79

Seasonality Move:

5.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-04-29	10Q	EW/Edwards Lifesciences Corp. Quarterly
2024-02-12	10K	EW/Edwards Lifesciences Corp. Annual
2023-10-27	10Q	EW/Edwards Lifesciences Corp. Quarterly
2023-07-28	10Q	EW/Edwards Lifesciences Corp. Quarterly
2023-04-28	10Q	EW/Edwards Lifesciences Corp. Quarterly
2023-02-13	10K	EW/Edwards Lifesciences Corp. Annual

Receive EW News And Ratings

See the #1 stock for the next 7 days that we like better than EW

EW Financial Statistics

Sales & Book Value

Annual Sales:	$6.1B
Cash Flow:	$516.2M
Price / Cash Flow:	56.66
Annual Sales:	$17.57
Price / Book:	4.54

Profitability

EPS (TTM):	1.85270
Net Income (TTM):	$1.1B
Gross Margin:	$4.7B
Return on Equity:	13.19%
Return on Assets:	7.99%

Edwards Lifesciences Corp. Earnings Forecast

Key Edwards Lifesciences Corp. Financial Ratios

The Gross Profit Margin over the past 30 years for EW is 78.13%.
The Selling, General & Administrative Expenses for EW have been equal to 34.37% of Gross Profit Margin.
The Research & Development expenses have been 17.79% of Revenue.
The Interest Expense is 0.00% of Operating Income.
The Net Earning history of EW is 17.40% of Total Revenues.
Per Share Earnings over the last 30 years have been positive in 19 years.

Edwards Lifesciences Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	S&P500
Industry:	Health Care Equipment & Supplies
Sector:	Health Care
Current Symbol:	EW
CUSIP:	28176E
Website:	edwards.com

Debt

Debt-to-Equity Ratio:	0.07
Current Ratio:	4
Quick Ratio:	2.86

Price-to-Earnings

Trailing P/E Ratio:	43.6
Forward P/E Ratio:	24.17

EW Technical Analysis vs Fundamental Analysis

Buy

Edwards Lifesciences Corp. (EW) is a Buy

Is Edwards Lifesciences Corp. a Buy or a Sell?

Edwards Lifesciences Corp. stock is rated a Buy

The current Edwards Lifesciences Corp. [EW] share price is $79.78. The Score for EW is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.